Ascensia Contour Glucose Meter

Ascensia Contour Glucose Meter

Ascensia Contour Glucose Meter ->->->-> https://urluss.com/2tkBTm

*Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. Do not calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

With the Contour XT blood glucose meter (formerly the Bayer Contour XT blood glucose meter), you can rely on reliable and accurate readings, day in and day out. The Contour XT meter is very easy to use. Thanks to the Multi-Pulse technology, every drop of blood is tested 7 times. The result is already displayed within 5 seconds. Thanks to the No-Coding technology, it prevents coding errors. The device features Second-Chance technology that makes it easy to apply additional blood when there is insufficient blood on the test strip for an accurate measurement. An advantage of this glucose meter is that it codes itself and gives a signal when insufficient blood has been added. This Contour XT starter pack comes in a handy pouch. NB! The blood sugar level is shown in mmol/L.

The Bayer Contour Control Solution is designed to check the accuracy of your glucose meter and test strips. Simply apply a drop of this glucometer control solution to a test strip and run a standard glucose test. Confirm that the test results are within the accepted range printed on the test strip vial. It is advised to test your glucose meter and strips accuracy on a regular basis. Designed for use with the Bayer Contour or Microfill glucose meters only.

Methods: Diabetes patients undergoing venipuncture for glucose testing were randomized to one of two groups consisting of three meters: FreeStyle Flash (Abbott Diabetes Care, Alameda, CA), Accu-Chek Advantage (Roche Diagnostics Corp., Indianapolis, IN), and Accu-Chek Compact Plus (Roche Diagnostics) or FreeStyle Flash, Ascensia Contour (Bayer Healthcare, Diagnostic Division, Tarrytown, NY), and BD Logic (BD Diabetes Care, Franklin Lake, NJ). Within 5 min following venipuncture, duplicate finger BG measurements from three ipsilateral fingers were taken. Finger glucose measurements were compared with laboratory reference values. Accuracy was assessed by a Clarke error grid analysis (EGA) and within 10% of the laboratory value criteria. Meter precision was determined by calculating the absolute mean differences in glucose values between duplicate samples.

The Forbes Health editorial team examined data on the top glucose meters available to determine the best glucose meters of 2023. Factors considered include required blood sample size, cost and special features. Blood glucose meters that require a finger stick test are the focal point of this analysis. Read on to discover our top picks.

The True Metrix Self-Monitoring Blood Glucose Meter snags the top spot on our ranking due to its affordability, its ability to deliver results in a speedy four seconds and its tiny required sample size. This glucose meter also boasts features including an impressive memory storage space of up to 500 results, alternate site testing and seven, 13 and 30-day averaging capabilities.

This glucose meter is chock-full of features, including alternate site testing (from the fingertip or forearm), memory storage of up to 1,000 results, averaging (seven, 14, 30, 60 and 90-day), event tagging and testing reminder alarms. Additionally, it boasts Bluetooth compatibility with its accompanying app, and its Triple Sense Technology is designed to deliver accurate results.

This no-frills glucose meter is affordable and easy to use, as it features a large, backlit display for easy viewing, non-slip rubber grips for easy handling and testing reminder alarms. Additionally, it features mealtime averaging to help identify patterns, a 14, 30 and 90-day averaging feature and custom hypo- and hyperglycemic alarms.

This affordable glucose meter offers glucose and ketone testing, which could be helpful for people with diabetes because when your body cannot use glucose for energy, it breaks down fat for energy, resulting in ketones. High ketone levels can make your blood acidic and could lead to a common diabetes complication called ketoacidosis.

People with diabetes have difficulty regulating glucose, a sugar used by the body for energy. Checking your blood glucose levels regularly with a glucose meter is important, as your blood glucose levels can go up or down based on what you eat or drink. Keeping those levels within the target range helps improve energy and mood while preventing or delaying serious health complications, such as:

To check your blood glucose levels, begin by thoroughly washing your hands. Place a test strip into the device before pricking your finger. Prick your finger with a lancing device and place a small amount of blood on a test strip. Insert the test strip into the meter to receive a blood glucose level reading.

Several brands offer free glucose meters for qualifying individuals. Some insurance providers and Medicare plans also offer coverage for glucose meters. Check with your preferred glucose meter brands and your insurance provider to see if you qualify for a free glucose meter.

Blood glucose self-testing equipment and supplies provided by participating suppliers are covered by Medicare. Check with the supplier of your glucose meter to determine whether they participate in Medicare to guarantee coverage.

Layout table for study information Study Type : Interventional (Clinical Trial) ActualEnrollment : 47 participants Allocation: N/A Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Supportive Care Official Title: US ONYX 2.0 Study: A Clinical Study of the Onyx 2.0 System for Blood Glucose Monitoring in Patients With Diabetes Actual Study Start Date : March 17, 2017 Actual Primary Completion Date : May 12, 2017 Actual Study Completion Date : May 12, 2017 Resource links provided by the National Library of Medicine MedlinePlus related topics: Blood Sugar U.S. FDA Resources Arms and Interventions Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Arm Intervention/treatment Experimental: Users of the Onyx Blood Glucose Meter/ app System at homeParticipants have a diagnosis of either type 1 or type 2 diabetes for at least 6 months and use insulin. Device: Onyx BG Meter / App SystemSubjects with diabetes used the Onyx BG Meter / App System at home and assessed the features of the App. Outcome Measures Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Primary Outcome Measures : Percent of Responses From Persons With Diabetes That 'Strongly Agree' or 'Agree' or 'Neither Agree Nor Disagree' With Questionnaire Statements Regarding Success With Syncing the Reading on the Onyx Glucose Meter and App. [ Time Frame: 6 weeks ]Staff obtained responses from persons with diabetes using short questionnaires to provide feedback on the success of syncing the blood glucose value on the meter with the App for the Onyx Glucose Meter and App System. Subjects could respond '1Strongly Agree' or '2Agree' or '3Neither Agree nor Disagree' or '4Disagree' or '5Strongly Disagree' or '6No Opinion'. Percent of Responses From Persons With Diabetes That Either 'Strongly Agree' or 'Agree' or 'Neither Agree Nor Disagree' With Questionnaire Statements Regarding Success in Accessing and Using Smart Reminders Feature in the Onyx App System [ Time Frame: 6 weeks ]Staff obtained responses from persons with diabetes using short questionnaires to provide feedback on accessing and using the Smart Reminders feature in the Onyx App System. Subjects could respond '1Strongly Agree' or '2Agree' or '3Neither Agree nor Disagree' or '4Disagree' or '5Strongly Disagree' or '6No Opinion'.Recognize and use \"Smart Reminders\" Percent of Responses From Persons With Diabetes That Either 'Strongly Agree' or 'Agree' or Are 'Neither Agree Nor Disagree' With Questionnaire Statements Regarding Success at Accessing the Expanded Graph and My Readings View in the Onyx App System [ Time Frame: 6 weeks ]Staff obtained responses from persons with diabetes using short questionnaires to provide feedback on the subjects ability to access the Expanded Graph and My Readings views in Onyx App System. Subjects could respond '1Strongly Agree' or '2Agree' or '3Neither Agree nor Disagree' or '4Disagree' or '5Strongly Disagree' or '6No Opinion'. Percent of Responses From Persons With Diabetes That Either 'Strongly Agree' or 'Agree' or Are 'Neither Agree Nor Disagree' With Questionnaire Statements Regarding Success in Interpreting the Expanded Graph and My Readings View in the Onyx App System [ Time Frame: 6 weeks ]Staff obtained responses from persons with diabetes using short questionnaires to provide feedback on the subjects ability to interpret the Expanded Graph and My Readings views in Onyx the App System. Subjects could respond '1Strongly Agree' or '2Agree' or '3Neither Agree nor Disagree' or '4Disagree' or '5Strongly Disagree' or '6No Opinion'. Secondary Outcome Measures : Change in HbA1c% From Study Start to End of Study [ Time Frame: 6 weeks ]Laboratory reports were used to compare HbA1c results from subjects at visit 1 with HbA1c results at Visit 2 (end of study). The average change of HbA1c for all subjects at Visit 1 were compared to the average change of HbA1c for all subjects at Visit 2. Lower scores are better outcomes. Change in Fructosamine (µmol/L) From Study Start to End of Study [ Time Frame: 6 Weeks ]Laboratory reports were used to compare fructosamine results from subjects at visit 1 with frustosamine results at Visit 2 (end of study). Average Change in Subject Body Weight From Study Start to End of Study [ Time Frame: 6 weeks ]The average change in subject body weight from study start (Visit 1) to end of study (Visit 2). Average Change in Subject BMI From Study Start to End of Study [ Time Frame: 6 weeks ]Subject BMI results at visit 1 were compared with BMI results at Visit 2 (end of study). Average Change in Total Daily Insulin Dose From Study Start to End of Study [ Time Frame: 6 weeks ]A Subjects' self-reported Total Daily Insulin Doses at visit 1 were compared with their self-reported Total Daily Insulin Doses at Visit 2 (end of study). Eligibility CriteriaGo to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Layout table for eligibility information Ages Eligible for Study: 18 Years to 75 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: 59ce067264

https://www.vascularandwoundexpert.com/forum/general-discussions/reclaim